Table II.
Lesion intensitya with the indicated virus |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Clinical signs | Day 5 p.i. |
Day 8 p.i. |
Day 13 p.i. |
|||||||||
Wild-type | MYXV-ΔM148R | MYXV-ΔM149R | MYXV-ΔM148R ΔM149R | Wild-type | MYXV-ΔM148R | MYXV-ΔM149R | MYXV-ΔM148R ΔM149R | Wild-type | MYXV-ΔM148R | MYXV-ΔM149R | MYXV-ΔM148R ΔM149R | |
Primary siteb: Perivascular dermatitis | ||||||||||||
Epidermal spongiosis and vesicles | – | – | – | – | ++++ | + | +++ | + | + | + | + | – |
Edema | +++ | +++ | +++/++++ | ++/+++ | ++++ | +++ | ++ | ++ | +++ | ++ | +++ | ++ |
Focal interstitial microhaemorrages | – | + | ++ | – | ++ | + | ++ | + | ++ | – | +++ | – |
Focal thrombosis | + | + | – | + | ++ | + | ++ | + | – | – | ++ | + |
Heterophils | ++/+++ | ++/+++ | ++/+++ | ++/+++ | ++++ | ++ | +++ | ++ | +++ | + | ++ | + |
Mononuclear cells | + | + | + | + | ++ | ++++ | ++ | ++++ | +++ | ++++ | +++ | ++++ |
Activated fibroblasts | ++ | ++ | ++ | ++ | +++ | +++ | +++ | +++ | +++++ | +++ | +++ | +++ |
Interstitial mucinosis | +++ | +++ | +++ | ++ | +++ | ++ | +++ | +++ | ++++ | ++ | +++ | ++ |
Secondary sitesc: Lymphadenitis | ||||||||||||
Lymphodepletion | – | – | – | – | – | – | – | – | – | – | – | |
Lymphoid hyperplasia | ++/+++ | ++ | ++ | ++ | +++ | +++ | +++ | ++ | ++ | ++ | ++ | |
Focal histiocytosis | ++++ | +++ | +++/++++ | ++/+++ | +++ | +++ | +++ | +++ | ++ | +++ | +/– | |
Infiltration by heterophils | +++ | +++ | +++ | ++ | +++ | ++ | +++ | + | – | + | – | |
Activated fibroblasts | – | – | – | – | +++ | ++ | ++ | + | – | + | – | |
Interstitial mucinosis | – | – | – | – | +++ | + | + | + | – | – | – |
Lesion intensity: +, minimal; ++, mild; +++, moderate; ++++, marked or +++++, severe.
Samples were taken from lesions at the inoculation site (ear).
Samples were taken from parotid lymph nodes. Main cells of inflammatory response are highlighted.